This company has been marked as potentially delisted and may not be actively trading. IGM Biosciences (IGMS) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Get the Latest News and Ratings for IGMS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for IGM Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IGMS Analyst Ratings Over TimeTypeCurrent Forecast9/20/24 to 9/20/251 Month Ago8/21/24 to 8/21/253 Months Ago6/22/24 to 6/22/251 Year Ago9/21/23 to 9/20/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)4 Buy rating(s)Hold8 Hold rating(s)9 Hold rating(s)9 Hold rating(s)4 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$4.89$5.50$5.50$16.63Forecasted Upside284.95% Upside333.07% Upside370.09% Upside2.88% UpsideConsensus RatingReduceReduceReduceModerate Buy IGMS Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History IGMS Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table IGM Biosciences Stock vs. The CompetitionTypeIGM BiosciencesMedical CompaniesS&P 500Consensus Rating Score 1.89 2.78 2.53Consensus RatingReduceModerate BuyModerate BuyPredicted Upside284.95% Upside14,898.02% Upside11.31% UpsideNews Sentiment RatingNeutral NewsSee Recent IGMS NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails1/13/2025JPMorgan Chase & Co.2 of 5 starsEric Joseph Not RatedUpgradeUnderweight ➝ Neutral1/10/2025Jefferies Financial Group2 of 5 starsRoger Song Not RatedReiterated RatingBuy ➝ Hold$48.00 ➝ $2.00-5.21%1/10/2025Truist Financial3 of 5 starsA. Goonewardene Not RatedLower TargetHold$12.00 ➝ $2.00+3.09%1/10/2025WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingR. DriscollSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$22.00 ➝ $3.00+53.06%1/10/2025Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeEqual Weight ➝ Underweight$12.00 ➝ $2.00-67.74%1/10/2025Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingStephen WilleySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Hold$27.00 ➝ $2.50-59.68%1/10/2025Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingB. AbrahamsSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Sector Perform$20.00 ➝ $1.50-75.81%1/10/2025GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingM. SchmidtSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral1/10/2025BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingE. DaroutSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$21.00 ➝ $2.00-67.74%9/5/2024HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetNeutral$12.00 ➝ $11.00+5.77% Get the Latest News and Ratings for IGMS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGM Biosciences and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating DowngradeBuy ➝ Neutral$8.00+23.08%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 02:03 AM ET. IGMS Forecast - Frequently Asked Questions What is IGM Biosciences' forecast for 2025? According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for IGM Biosciences is $4.89, with a high forecast of $20.00 and a low forecast of $1.50. Should I buy or sell IGM Biosciences stock right now? 9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IGM Biosciences in the last twelve months. There is currently 1 sell rating and 8 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" IGMS shares. Does IGM Biosciences's stock price have much upside? According to analysts, IGM Biosciences's stock has a predicted upside of 284.95% based on their 12-month stock forecasts. Do Wall Street analysts like IGM Biosciences more than its competitors? Analysts like IGM Biosciences less than other "medical" companies. The consensus rating for IGM Biosciences is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how IGMS compares to other companies. Stock Forecasts and Research Tools Related Companies MNPR Stock Forecast SCPH Stock Forecast GLUE Stock Forecast MREO Stock Forecast FHTX Stock Forecast ENGN Stock Forecast CAPR Stock Forecast KRRO Stock Forecast LFCR Stock Forecast LXEO Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:IGMS) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
